Le Lézard
Classified in: Health
Subject: TRD

Chardan Healthcare Acquisition Corp. Securities To Commence Separate Trading


NEW YORK, March 12, 2019 /PRNewswire/ -- Chardan Healthcare Acquisition Corp. (NYSE American: CHAC.U) (the "Company") announced today that separate trading of its common stock and warrants underlying the Company's units would commence on or about March 13, 2019. The common stock and warrants will trade under the symbols "CHAC" and "CHAC.W", respectively. Units not separated will continue to be listed on NYSE American under the symbol "CHAC.U."

Chardan Healthcare Acquisition Corp. is a blank check company organized for the purpose of effecting a business combination with one or more target businesses. Chardan Healthcare Acquisition Corp.'s efforts to identify a prospective target business will not be limited to a particular industry or geographic region, although it intends to focus its search on target businesses operating in North America in the healthcare industry.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Forward Looking Statements

This press release may contain forward-looking statements within the meaning of the federal securities laws.  These forward-looking statements inherently involve risks and uncertainties that are detailed in the companies' registration statements and other filings with the Securities and Exchange Commission and, therefore, actual results could differ materially from those projected in the forward-looking statements.  The companies assume no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Company:

Chardan Healthcare Acquisition Corp.
Jonas Grossman, CEO
17 State Street, 21st Floor, New York, NY 10004
(646) 465-9002

SOURCE Chardan Healthcare Acquisition Corp.


These press releases may also interest you

at 04:00
Nearly all American adults (95%) agree stroke is an emergency, yet according to new omnibus survey by The Harris Poll on behalf of the Get Ahead of Stroke® campaign, less than half (43%) say they would call 911 if they were experiencing a common...

at 04:00
Pan-Canadian children's health advocate Children's Healthcare Canada is calling on the federal government to show political will to solve the crises plaguing children's healthcare and declare children's health and well-being a national priority. ...

at 03:44
21st.BIO unveiled a new pilot plant facility in its Danish...

at 03:05
Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, today announced its investment in a second manufacturing line for the production of pressurized metered-dose inhaler (pMDI) products containing low-GWP (Global...

at 03:05
Lantern Pharma Inc. , a leading artificial intelligence (AI) oncology drug discovery and development company, today announced a strategic AI-driven collaboration with French biotechnology company, Oregon Therapeutics to optimize the development of...

at 03:00
Patients with spinal cord injury (SCI) could benefit from future treatment to repair nerve connections using red and near-infrared light....



News published on and distributed by: